![]() |
同义名 : | - |
CAS号 : | 1793053-37-8 | |
货号 : | A434113 | |
分子式 : | C36H42N6O | |
纯度 : | 99%+ | |
分子量 : | 574.76 | |
MDL号 : | MFCD28902312 | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | LLY-507 is a potent and selective SMYD2 inhibitor with IC50 value <15nM, >100-fold selective for SMYD2 over a broad range of methyltransferase and non-methyltransferase targets. LLY-507 inhibited SMYD2-induced p53 methylation in U2OS cells with an IC50 of 0.6μM. Inhibition of SMYD2 by LLY-507 did not significantly affect cellular global histone methylation levels for SMYD2 targeted a very small subset of histones at specific chromatin loci and/or non-histone substrates. LLY-507 inhibited the proliferation of several esophageal, liver, and breast cancer cell lines in a dose-dependent manner, with IC50 values<10μM post 3 days or 7 days[2]. | ||
作用机制 | LLY-507 binds in the substrate peptide binding pocket.[2] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.74mL 0.35mL 0.17mL |
8.70mL 1.74mL 0.87mL |
17.40mL 3.48mL 1.74mL |
参考文献 |
---|